Aktie A401NR PROMINO NUTRITIONAL SCIENCES
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Promino Nutritional Sciences Canadian Securities Exchange

Aktien

A401NR

CA74290V1058

MUSL

Verzögert Canadian Securities Exchange
Andere Börsenplätze
 15:39:47 05.07.2024 		% 5 Tage % 1. Jan.
0,145 CAD 0,00 % Intraday Chart für Promino Nutritional Sciences +3,57 % -19,44 %
31.05. Promino Nutritional Sciences Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
21.05. Promino Nutritional Sciences führt präklinische Studien durch, um die Wirksamkeit von Promino bei der Bekämpfung des Muskelabbaus durch Ozempic und andere GLP-1-basierte Gewichtsreduktionsmittel zu untersuchen CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Promino Nutritional Sciences Inc. to Receive 65,000 Total Units Of New Rejuvenate Muscle Health™ And Promino™, Achieves Another Key Comeback Milestone On Schedule
Promino Nutritional Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Promino Nutritional Sciences Inc. announced that it expects to receive CAD 3 million in funding
PROMINO NUTRITIONAL SCIENCES INC. SIGNS AGREEMENT WITH LAS VEGAS LIGHTS FC OF USL CHAMPIONSHIP TO MAKE PROMINO™ "THE OFFICIAL PROTEIN DRINK OF THE LAS VEGAS LIGHTS"
Promino Nutritional Sciences to Conduct Preclinical Trials Evaluating Promino's Effectiveness in Fighting Muscle Loss Caused by Ozempic and other GLP- 1 Based Weight Loss Treatments
Promino Nutritional Sciences to Conduct Preclinical Trials Evaluating Promino's Effectiveness in Fighting Muscle Loss Caused by Ozempic and Other GLP- 1 Based Weight Loss Treatments
Promino Nutritional Sciences and Dr. Patrick Gunning to Begin Preclinical Studies Focused on Targeted Nutritional Supplementation for Cancer Patients
Promino Nutritional Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
PROMINO NUTRITIONAL SCIENCES ACCELERATES REJUVENATE MUSCLE ACTIVATOR™ E-COMMERCE EXPANSION AHEAD OF JUNE RELAUNCH
PROMINO NUTRITIONAL SCIENCES WELCOMES SIX TIME MLB ALL-STAR JOSÉ BAUTISTA AS BRAND AMBASSADOR
Promino Nutritional Sciences Inc. entered into a binding letter of intent to acquire Helios Helium Corp. for CAD 5.84 million.
Promino Nutritional Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Promino Nutritional Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Promino Nutritional Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Promino Nutritional Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. MUSL Aktie
  4. A401NR Aktie
  5. Nachrichten Promino Nutritional Sciences
  6. Andere Sprachen